Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON39949Phase 2Not yet recruiting
Phase 2, randomised, open-label trial of amoxicillin + clavulanate in aspiration pneumonia (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Number of definite and/or suspected pneumonia. Planned start Jun 2011; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON39949.